ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parkinson Treatment Drug Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-37Q12262
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Parkinson Treatment Drug Market Research Report 2022
BUY CHAPTERS

Global Parkinson Treatment Drug Market Research Report 2025

Code: QYRE-Auto-37Q12262
Report
March 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Akorn
Teva Pharmaceutical
AbbVie
Kyowa Hakko Kirin Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Boehringer Ingelheim
Novartis
GSK
Astellas Pharma

Parkinson Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Parkinson Treatment Drug Market

Parkinson Treatment Drug Market

The global market for Parkinson Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Parkinson Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson Treatment Drug.
The Parkinson Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parkinson Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Parkinson Treatment Drug Market Report

Report Metric Details
Report Name Parkinson Treatment Drug Market
CAGR 5%
Segment by Type
Segment by Application
  • Male Patient
  • Female Patient
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Parkinson Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Parkinson Treatment Drug Market report?

Ans: The main players in the Parkinson Treatment Drug Market are Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health

What are the Application segmentation covered in the Parkinson Treatment Drug Market report?

Ans: The Applications covered in the Parkinson Treatment Drug Market report are Male Patient, Female Patient

What are the Type segmentation covered in the Parkinson Treatment Drug Market report?

Ans: The Types covered in the Parkinson Treatment Drug Market report are Sinemet-CR, Piribedil, Madopar, COMT Inhibitor, Others

Recommended Reports

Neurological Disease Drugs

Chronic Disease Therapies

Therapy Devices & Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sinemet-CR
1.2.3 Piribedil
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Others
1.3 Market by Application
1.3.1 Global Parkinson Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Male Patient
1.3.3 Female Patient
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson Treatment Drug Market Perspective (2020-2031)
2.2 Global Parkinson Treatment Drug Growth Trends by Region
2.2.1 Global Parkinson Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Parkinson Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Parkinson Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Parkinson Treatment Drug Market Dynamics
2.3.1 Parkinson Treatment Drug Industry Trends
2.3.2 Parkinson Treatment Drug Market Drivers
2.3.3 Parkinson Treatment Drug Market Challenges
2.3.4 Parkinson Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson Treatment Drug Players by Revenue
3.1.1 Global Top Parkinson Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Parkinson Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Parkinson Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Parkinson Treatment Drug Revenue
3.4 Global Parkinson Treatment Drug Market Concentration Ratio
3.4.1 Global Parkinson Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson Treatment Drug Revenue in 2024
3.5 Global Key Players of Parkinson Treatment Drug Head office and Area Served
3.6 Global Key Players of Parkinson Treatment Drug, Product and Application
3.7 Global Key Players of Parkinson Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson Treatment Drug Breakdown Data by Type
4.1 Global Parkinson Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Parkinson Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Parkinson Treatment Drug Breakdown Data by Application
5.1 Global Parkinson Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Parkinson Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Parkinson Treatment Drug Market Size (2020-2031)
6.2 North America Parkinson Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Parkinson Treatment Drug Market Size by Country (2020-2025)
6.4 North America Parkinson Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson Treatment Drug Market Size (2020-2031)
7.2 Europe Parkinson Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Parkinson Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Parkinson Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Parkinson Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Parkinson Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Parkinson Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson Treatment Drug Market Size (2020-2031)
9.2 Latin America Parkinson Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Parkinson Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Parkinson Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Parkinson Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Parkinson Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Parkinson Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson Treatment Drug Introduction
11.1.4 Merck Revenue in Parkinson Treatment Drug Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson Treatment Drug Introduction
11.2.4 Akorn Revenue in Parkinson Treatment Drug Business (2020-2025)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson Treatment Drug Introduction
11.3.4 GSK Revenue in Parkinson Treatment Drug Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson Treatment Drug Introduction
11.4.4 Novartis Revenue in Parkinson Treatment Drug Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson Treatment Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson Treatment Drug Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson Treatment Drug Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson Treatment Drug Business (2020-2025)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson Treatment Drug Introduction
11.7.4 Abbvie Revenue in Parkinson Treatment Drug Business (2020-2025)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Treatment Drug Business (2020-2025)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson Treatment Drug Introduction
11.9.4 Astellas Pharma Revenue in Parkinson Treatment Drug Business (2020-2025)
11.9.5 Astellas Pharma Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson Treatment Drug Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson Treatment Drug Business (2020-2025)
11.10.5 Desitin Arzneimittel Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Details
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson Treatment Drug Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson Treatment Drug Business (2020-2025)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson Treatment Drug Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Treatment Drug Business (2020-2025)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Details
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson Treatment Drug Introduction
11.13.4 H.Lundbeck Revenue in Parkinson Treatment Drug Business (2020-2025)
11.13.5 H.Lundbeck Recent Development
11.14 Valeant
11.14.1 Valeant Company Details
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson Treatment Drug Introduction
11.14.4 Valeant Revenue in Parkinson Treatment Drug Business (2020-2025)
11.14.5 Valeant Recent Development
11.15 Apokyn
11.15.1 Apokyn Company Details
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson Treatment Drug Introduction
11.15.4 Apokyn Revenue in Parkinson Treatment Drug Business (2020-2025)
11.15.5 Apokyn Recent Development
11.16 Orion
11.16.1 Orion Company Details
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson Treatment Drug Introduction
11.16.4 Orion Revenue in Parkinson Treatment Drug Business (2020-2025)
11.16.5 Orion Recent Development
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Details
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson Treatment Drug Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson Treatment Drug Business (2020-2025)
11.17.5 Stada Arzneimittel Recent Development
11.18 US WorldMeds
11.18.1 US WorldMeds Company Details
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson Treatment Drug Introduction
11.18.4 US WorldMeds Revenue in Parkinson Treatment Drug Business (2020-2025)
11.18.5 US WorldMeds Recent Development
11.19 Bausch Health
11.19.1 Bausch Health Company Details
11.19.2 Bausch Health Business Overview
11.19.3 Bausch Health Parkinson Treatment Drug Introduction
11.19.4 Bausch Health Revenue in Parkinson Treatment Drug Business (2020-2025)
11.19.5 Bausch Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck
Akorn
Teva Pharmaceutical
AbbVie
Kyowa Hakko Kirin Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Boehringer Ingelheim
Novartis
GSK
Astellas Pharma
List of Tables
 Table 1. Global Parkinson Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Sinemet-CR
 Table 3. Key Players of Piribedil
 Table 4. Key Players of Madopar
 Table 5. Key Players of COMT Inhibitor
 Table 6. Key Players of Others
 Table 7. Global Parkinson Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Parkinson Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Parkinson Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Parkinson Treatment Drug Market Share by Region (2020-2025)
 Table 11. Global Parkinson Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Parkinson Treatment Drug Market Share by Region (2026-2031)
 Table 13. Parkinson Treatment Drug Market Trends
 Table 14. Parkinson Treatment Drug Market Drivers
 Table 15. Parkinson Treatment Drug Market Challenges
 Table 16. Parkinson Treatment Drug Market Restraints
 Table 17. Global Parkinson Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Parkinson Treatment Drug Market Share by Players (2020-2025)
 Table 19. Global Top Parkinson Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Treatment Drug as of 2024)
 Table 20. Ranking of Global Top Parkinson Treatment Drug Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Parkinson Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Parkinson Treatment Drug, Headquarters and Area Served
 Table 23. Global Key Players of Parkinson Treatment Drug, Product and Application
 Table 24. Global Key Players of Parkinson Treatment Drug, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Parkinson Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Parkinson Treatment Drug Revenue Market Share by Type (2020-2025)
 Table 28. Global Parkinson Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Parkinson Treatment Drug Revenue Market Share by Type (2026-2031)
 Table 30. Global Parkinson Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Parkinson Treatment Drug Revenue Market Share by Application (2020-2025)
 Table 32. Global Parkinson Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Parkinson Treatment Drug Revenue Market Share by Application (2026-2031)
 Table 34. North America Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Parkinson Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Parkinson Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Parkinson Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Parkinson Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Parkinson Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Parkinson Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Parkinson Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Parkinson Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Parkinson Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Parkinson Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Parkinson Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Merck Company Details
 Table 50. Merck Business Overview
 Table 51. Merck Parkinson Treatment Drug Product
 Table 52. Merck Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 53. Merck Recent Development
 Table 54. Akorn Company Details
 Table 55. Akorn Business Overview
 Table 56. Akorn Parkinson Treatment Drug Product
 Table 57. Akorn Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 58. Akorn Recent Development
 Table 59. GSK Company Details
 Table 60. GSK Business Overview
 Table 61. GSK Parkinson Treatment Drug Product
 Table 62. GSK Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 63. GSK Recent Development
 Table 64. Novartis Company Details
 Table 65. Novartis Business Overview
 Table 66. Novartis Parkinson Treatment Drug Product
 Table 67. Novartis Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 68. Novartis Recent Development
 Table 69. Boehringer Ingelheim Company Details
 Table 70. Boehringer Ingelheim Business Overview
 Table 71. Boehringer Ingelheim Parkinson Treatment Drug Product
 Table 72. Boehringer Ingelheim Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 73. Boehringer Ingelheim Recent Development
 Table 74. Teva Pharmaceutical Company Details
 Table 75. Teva Pharmaceutical Business Overview
 Table 76. Teva Pharmaceutical Parkinson Treatment Drug Product
 Table 77. Teva Pharmaceutical Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 78. Teva Pharmaceutical Recent Development
 Table 79. Abbvie Company Details
 Table 80. Abbvie Business Overview
 Table 81. Abbvie Parkinson Treatment Drug Product
 Table 82. Abbvie Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 83. Abbvie Recent Development
 Table 84. Kyowa Hakko Kirin Pharma Company Details
 Table 85. Kyowa Hakko Kirin Pharma Business Overview
 Table 86. Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product
 Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 88. Kyowa Hakko Kirin Pharma Recent Development
 Table 89. Astellas Pharma Company Details
 Table 90. Astellas Pharma Business Overview
 Table 91. Astellas Pharma Parkinson Treatment Drug Product
 Table 92. Astellas Pharma Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 93. Astellas Pharma Recent Development
 Table 94. Desitin Arzneimittel Company Details
 Table 95. Desitin Arzneimittel Business Overview
 Table 96. Desitin Arzneimittel Parkinson Treatment Drug Product
 Table 97. Desitin Arzneimittel Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 98. Desitin Arzneimittel Recent Development
 Table 99. Endo Pharmaceuticals Company Details
 Table 100. Endo Pharmaceuticals Business Overview
 Table 101. Endo Pharmaceuticals Parkinson Treatment Drug Product
 Table 102. Endo Pharmaceuticals Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 103. Endo Pharmaceuticals Recent Development
 Table 104. F.Hoffmann-La Roche Company Details
 Table 105. F.Hoffmann-La Roche Business Overview
 Table 106. F.Hoffmann-La Roche Parkinson Treatment Drug Product
 Table 107. F.Hoffmann-La Roche Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 108. F.Hoffmann-La Roche Recent Development
 Table 109. H.Lundbeck Company Details
 Table 110. H.Lundbeck Business Overview
 Table 111. H.Lundbeck Parkinson Treatment Drug Product
 Table 112. H.Lundbeck Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 113. H.Lundbeck Recent Development
 Table 114. Valeant Company Details
 Table 115. Valeant Business Overview
 Table 116. Valeant Parkinson Treatment Drug Product
 Table 117. Valeant Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 118. Valeant Recent Development
 Table 119. Apokyn Company Details
 Table 120. Apokyn Business Overview
 Table 121. Apokyn Parkinson Treatment Drug Product
 Table 122. Apokyn Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 123. Apokyn Recent Development
 Table 124. Orion Company Details
 Table 125. Orion Business Overview
 Table 126. Orion Parkinson Treatment Drug Product
 Table 127. Orion Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 128. Orion Recent Development
 Table 129. Stada Arzneimittel Company Details
 Table 130. Stada Arzneimittel Business Overview
 Table 131. Stada Arzneimittel Parkinson Treatment Drug Product
 Table 132. Stada Arzneimittel Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 133. Stada Arzneimittel Recent Development
 Table 134. US WorldMeds Company Details
 Table 135. US WorldMeds Business Overview
 Table 136. US WorldMeds Parkinson Treatment Drug Product
 Table 137. US WorldMeds Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 138. US WorldMeds Recent Development
 Table 139. Bausch Health Company Details
 Table 140. Bausch Health Business Overview
 Table 141. Bausch Health Parkinson Treatment Drug Product
 Table 142. Bausch Health Revenue in Parkinson Treatment Drug Business (2020-2025) & (US$ Million)
 Table 143. Bausch Health Recent Development
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources
 Table 147. Authors List of This Report


List of Figures
 Figure 1. Parkinson Treatment Drug Picture
 Figure 2. Global Parkinson Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Parkinson Treatment Drug Market Share by Type: 2024 VS 2031
 Figure 4. Sinemet-CR Features
 Figure 5. Piribedil Features
 Figure 6. Madopar Features
 Figure 7. COMT Inhibitor Features
 Figure 8. Others Features
 Figure 9. Global Parkinson Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Parkinson Treatment Drug Market Share by Application: 2024 VS 2031
 Figure 11. Male Patient Case Studies
 Figure 12. Female Patient Case Studies
 Figure 13. Parkinson Treatment Drug Report Years Considered
 Figure 14. Global Parkinson Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Parkinson Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Parkinson Treatment Drug Market Share by Region: 2024 VS 2031
 Figure 17. Global Parkinson Treatment Drug Market Share by Players in 2024
 Figure 18. Global Top Parkinson Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Treatment Drug as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Parkinson Treatment Drug Revenue in 2024
 Figure 20. North America Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Parkinson Treatment Drug Market Share by Country (2020-2031)
 Figure 22. United States Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Parkinson Treatment Drug Market Share by Country (2020-2031)
 Figure 26. Germany Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Parkinson Treatment Drug Market Share by Region (2020-2031)
 Figure 34. China Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Parkinson Treatment Drug Market Share by Country (2020-2031)
 Figure 42. Mexico Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Parkinson Treatment Drug Market Share by Country (2020-2031)
 Figure 46. Turkey Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Parkinson Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Merck Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 50. Akorn Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 51. GSK Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 52. Novartis Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 53. Boehringer Ingelheim Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 54. Teva Pharmaceutical Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 55. Abbvie Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 56. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 57. Astellas Pharma Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 58. Desitin Arzneimittel Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 59. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 60. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 61. H.Lundbeck Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 62. Valeant Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 63. Apokyn Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 64. Orion Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 65. Stada Arzneimittel Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 66. US WorldMeds Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 67. Bausch Health Revenue Growth Rate in Parkinson Treatment Drug Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Neurologic Disorder Treatment Drug Market Research Report 2024
Global Still s Disease Treatment Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Global PD 1 and PD L1 Inhibitor Market Research Report 2025
Global Medicines for Alzheimer Disease Treatment Market Research Report 2025
Global Alzheimer s Treatment Drug Market Research Report 2024
Global Tauopathies Treatment Market Research Report 2025
Global Major Depressive Disorder Drug Market Research Report 2025
Global Daylight Therapy Lamp Market Research Report 2025
Global Antidepressant Medication Market Research Report 2025
Global Early Diagnosis Kit For Alzheimer s Disease Market Research Report 2024
Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neurodegenerative Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retinal Disorder Treatment Market Research Report 2024
Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs of Abuse Testing Market Research Report 2024
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Specific Learning Disability Treatment Market Research Report 2025
Global Alzheimer s Clinical Treatment Drug Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions